semaglutide (NN9924)

	Next higher product group	GLP-1 analogue
	Status	2017-12-05 registration start
	Organisation	Novo Nordisk A/S
	Group	Novo Group (Group)

Record changed: 2020-12-15

Picture [iito] Plain Stupid Simple 650x80px

More documents for semaglutide (NN9924)

[1] Emisphere Technologies, Inc.. (11/6/20). "Press Release: Novo Nordisk to Acquire Emisphere Technologies for $1.35 Billion". Roseland, NJ....
[2] Gilead Sciences, Inc.. (4/12/19). "Press Release: Gilead Sciences and Novo Nordisk Announce Intent to Initiate a Clinical Collaboration in NASH". Foster City & Bagsvaerd....
[3] Novo Nordisk A/S. (8/20/18). "Press Release: Oral Semaglutide Provides Superior HbA1c and Weight Reductions versus Placebo in People with Type 2 Diabetes and Renal Impairment in the PIONEER 5 trial". Bagsvaerd....
[4] Novo Nordisk A/S. (8/8/18). "Press Release: Novo Nordisk’s Operating Profit Decreased by 8% in Danish Kroner and Increased by 4% in Local Currencies in the First Six Months of 2018"....
[5] Novo Nordisk A/S. (12/15/17). "Press Release: Ozempic (semaglutide) Recommended for Approval by the European Regulatory Authorities". Bagsvaerd....
[6] Novo Nordisk A/S. (12/5/17). "Press Release: Ozempic (semaglutide) Approved in the US". Bagsvaerd....
[7] Novo Nordisk A/S. (8/16/17). "Press Release: Semaglutide Superior to Dulaglutide on Glucose Control and Weight Loss in People with Type 2 Diabetes in SUSTAIN 7". Bagsvaerd....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Picture Berlin Partner Bionnale 2021 Digital Event 650x80px

» top

Top News

Upcoming Events

Management Appointments

Financings & Acquisitions

Collaborations & Licensing

At Investor Conferences

Bio Regions & Life Sciences Clusters

Business Parks & Science Centres

Associations

Advertise

semaglutide (NN9924)

More documents for semaglutide (NN9924)